Michela Croce

1.8k citations
47 papers · 1.2k indexed · 1 hit paper · h-index 21

Impact in

  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Neuroblastoma Research and Treatments 21
    • Immune Cell Function and Interaction 9
    • Immunotherapy and Immune Responses 6
    • interferon and immune responses 4

Michela Croce

45 papers receiving 1.1k citations

Hit Papers

Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade 2022 · 154 citations
154202220262023202450100150

Peers

Michela Croce
Comparison fields: 5 of 84
  • Immunology 510
  • Oncology 490
  • Neurology 237
  • Ophthalmology 134
  • Cancer Research 184
Replace Karin Wadt with:
Karin Wadt Denmark
Marta Nyakas Norway
Marcus Bosenberg United States
Lorena Lôbo de Figueiredo-Pontes Brazil
Rebecca E. Saunders United Kingdom
Xuhui Bao United States
Hojabr Kakavand Australia
W Zhang United States
Barbara C. Böck Germany
Timothy J. Purwin United States
Michela Croce relative to Karin Wadt Denmark Karin Wadt's profile →
Citations per field
00.5×8.5×
Karin Wadt · 1×
Citations per year

Countries citing papers authored by Michela Croce

Since Specialization
Citations

This map shows the geographic impact of Michela Croce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Croce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Croce more than expected).

Fields of papers citing papers by Michela Croce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Croce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Croce. The network helps show where Michela Croce may publish in the future.

Co-authors

The 25 scholars most cited alongside Michela Croce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michela Croce Line = papers co-authored together Michela Croce links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20238
3 20232
4 20224
5
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
Hit paper breakdown →
2022154
6 202132
7 202120
8 201922
9 201829
10 201517
11 201223
12 201126
13 201165
14 200932
15 200920
16 200828
17 200842
18 20079
19 200415
20 200325

About Michela Croce

Michela Croce is a scholar working on Neurology, Immunology, Ophthalmology, Oncology and Cancer Research, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (21 papers), Immune Cell Function and Interaction (9 papers), Ocular Oncology and Treatments (8 papers), Virus-based gene therapy research (7 papers), Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and interferon and immune responses (4 papers). The work is most often cited by research in Immunology (510 citations), Oncology (490 citations), Neurology (237 citations), Ophthalmology (134 citations) and Cancer Research (184 citations). Michela Croce has collaborated with scholars based in Italy, France and Netherlands. Frequent co-authors include Silvano Ferrini, Rosaria Gangemi, Maria Valeria Corrias, Ulrich Pfeffer, Gilberto Filaci, Vito Pistoia, Bruno Azzarone, Anna Maria Orengo, Simona Coco and Paolo Carrega. Their work appears in journals such as Cancers, International Journal of Molecular Sciences, Oncotarget, Cancer Immunology Immunotherapy and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026